Spots Global Cancer Trial Database for Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.
Official Title: A Randomized, Open-label Phase II Study Evaluating the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab as First-line Therapy in Subjects With Metastatic Colorectal Cancer.
Study ID: NCT00439517
Study Description
Brief Summary: This is an exploratory study to compare activity and safety in 400 patients with previously untreated metastatic carcinoma of the colon treated with UFOX (a combination regimen of UFT® (Tegafur plus Uracil), Oxaliplatin, Folinic Acid) plus Cetuximab or FOLFOX-4 (a combination regimen of 5 Fluorouracil (5-FU), Oxaliplatin and Folinic Acid) plus Cetuximab)
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Buenos Aires, , Argentina
Research Site, Ciudad Autónoma Buenos Aires, , Argentina
Research Site, Perth, , Australia
Research Site, Wollongong, , Australia
Research Site, Graz, , Austria
Research Site, Wien, , Austria
Research Site, Leuven, , Belgium
Research Site, Liège, , Belgium
Research Site, Belo Horizonte, , Brazil
Research site, Cep Sao Paulo-SP, , Brazil
Research Site, Fortaleza, , Brazil
Research Site, Besancon Cedex, , France
Research Site, Caen-Cedex 5, , France
Research Site, La Roche sur Yon, , France
Research Site, Lille, , France
Research Site, Marseille, , France
Research Site, Nice, , France
Research Site, Saint-Herblain, , France
Research Site, Strasbourg, , France
Research Site, Berlin, , Germany
Research Site, Dortmund, , Germany
Research Site, Dresden, , Germany
Research Site, Frankfurt / Main, , Germany
Research Site, Hamburg, , Germany
Research Site, Hannover, , Germany
Research Site, Heidelberg, , Germany
Research Site, Kassel, , Germany
Research Site, Krefeld, , Germany
Research Site, Magdeburg, , Germany
Research Site, München, , Germany
Research Site, Oldenburg, , Germany
Research Site, Wiesbaden, , Germany
Research Site, Dragana, , Greece
Research Site, Thessaloniki, , Greece
Research Site, Voutes, , Greece
Research Site, Hong Kong, , Hong Kong
Research Site, Sha Tin, , Hong Kong
Research Site, Haifa, , Israel
Research Site, Jerusalem, , Israel
Research Site, Benevento, , Italy
Research Site, Brescia, , Italy
Research Site, Cremona, , Italy
Research Site, Forli, , Italy
Research Site, Padova, , Italy
Research Site, Pavia, , Italy
Research Site, Potenza, , Italy
Research Site, Reggio Emilia, , Italy
Research Site, Rimini, , Italy
Research Site, Roma, , Italy
Research Site, Sassari, , Italy
Research Site, Mexico-City, , Mexico
Research Site, Krakow, , Poland
Research Site, Lublin, , Poland
Research Site, Opole, , Poland
Research Site, Warsaw, , Poland
Research Site, Bangkok, , Thailand
Research Site, Pathumwan, , Thailand
Contact Details
Name: Jean-Yves Douillard, MD PhD
Affiliation: Centre R Gauducheau
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
